Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-011075

Chief Scientific Officer sold 25,900 shares at an average $31.76 ($822,679)

  • Chief Scientific Officer acquired 25,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-02-18 Option exercise +18,500 $6.32 $116,920 89,179 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-18 Sale −18,500 $31.38 $580,530 70,679 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-19 Option exercise +7,400 $6.32 $46,768 78,079 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-19 Sale −3,500 $32.18 $112,630 74,579 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-19 Sale −3,900 $33.21 $129,519 70,679 D
Derivatives
ROBINS HARLAN S Chief Scientific Officer 2020-02-18 Option exercise · Stock Option (Right to Buy) −18,500 570,400 D
ROBINS HARLAN S Chief Scientific Officer 2020-02-19 Option exercise · Stock Option (Right to Buy) −7,400 563,000 D
Open-market sales · 25,900 sh · avg $31.76 · $822,679
Loading xslF345X03/doc4.xml…